Pleuroparenchymal fibroelastosis after haematopoietic stem cell transplantation without graft‐versus‐host disease findings
Authors:
Open Access
- 29 January 2018
- journal article
- case report
- Published by Wiley in Respirology Case Reports
- Vol. 6 (3) , e00298
Abstract
Although rare, pleuroparenchymal fibroelastosis (PPFE) is a serious late‐onset complication of haematopoietic stem cell transplantation (HSCT). It remains unclear whether graft‐versus‐host disease (GVHD) is involved in the development of PPFE. We report the case of a patient with PPFE after HSCT. The patient experienced pneumothorax repeatedly despite surgical treatment. A surgical specimen demonstrated PPFE findings, without evidence of GVHD. In this case, development of PPFE was not associated with GVHD, and immunosuppressive therapy did not improve pulmonary function. Surgical biopsy is recommended for precise treatment and elucidation of pathogenesis in each suspected PPFE patient.Keywords
This publication has 5 references indexed in Scilit:
- Pleuroparenchymal fibroelastosis: the prevalence of secondary forms in hematopoietic stem cell and lung transplantation recipientsDiagnostic and Interventional Radiology, 2016
- Air-leak Syndrome by Pleuroparenchymal Fibroelastosis after Bone Marrow TransplantationInternal Medicine, 2016
- Pleuroparenchymal fibroelastosis and non‐specific interstitial pneumonia: frequent pulmonary sequelae of haematopoietic stem cell transplantationHistopathology, 2014
- Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agentsEuropean Respiratory Journal, 2014
- Lung Toxicity Associated With Cyclophosphamide Use. Two Distinct PatternsAmerican Journal of Respiratory and Critical Care Medicine, 1996